Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]

Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-rela...

Full description

Bibliographic Details
Main Authors: Moetemri Zied, Samira Mhamdi, Ghedira Hela, Aida Ayadi, Selsabil Daboussi, Samia Essebaa, Chiraz Aichaouia
Format: Article
Language:English
Published: F1000 Research Ltd 2023-09-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/12-337/v3
_version_ 1827823198347984896
author Moetemri Zied
Samira Mhamdi
Ghedira Hela
Aida Ayadi
Selsabil Daboussi
Samia Essebaa
Chiraz Aichaouia
author_facet Moetemri Zied
Samira Mhamdi
Ghedira Hela
Aida Ayadi
Selsabil Daboussi
Samia Essebaa
Chiraz Aichaouia
author_sort Moetemri Zied
collection DOAJ
description Idiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-relapsing and steroid-dependent ICEP was made respectively. Mepolizumab was prescribed to both patients. This treatment resulted in successful long-term disease management with much fewer side effects than a traditional corticosteroid therapy.
first_indexed 2024-03-12T02:08:44Z
format Article
id doaj.art-f9ce65787cf5418f879adf5c7f9be5b0
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-03-12T02:08:44Z
publishDate 2023-09-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-f9ce65787cf5418f879adf5c7f9be5b02023-09-07T00:00:00ZengF1000 Research LtdF1000Research2046-14022023-09-0112155328Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]Moetemri Zied0Samira Mhamdi1https://orcid.org/0000-0003-3284-426XGhedira Hela2Aida Ayadi3Selsabil Daboussi4https://orcid.org/0000-0001-7732-8643Samia Essebaa5Chiraz Aichaouia6University of Tunis El Manar, Tunis, TunisiaUniversity of Tunis El Manar, Tunis, TunisiaUniversity of Tunis El Manar, Tunis, TunisiaUniversity of Tunis El Manar, Tunis, TunisiaUniversity of Tunis El Manar, Tunis, TunisiaPneumology, Military Hospital of Tunis, Tunis, 1008, TunisiaUniversity of Tunis El Manar, Tunis, TunisiaIdiopathic chronic eosinophilic pneumonia (ICEP) is a rare interstitial lung disease of unknown cause. It usually responds well to systemic corticosteroid therapy, but relapses are frequent. We describe two cases of 21- and 27-year-old patients, presenting with dyspnea. The diagnosis of steroid-relapsing and steroid-dependent ICEP was made respectively. Mepolizumab was prescribed to both patients. This treatment resulted in successful long-term disease management with much fewer side effects than a traditional corticosteroid therapy.https://f1000research.com/articles/12-337/v3Mepolizumab Idiopathic chronic eosinophilic pneumonia Corticosteroid Treatmenteng
spellingShingle Moetemri Zied
Samira Mhamdi
Ghedira Hela
Aida Ayadi
Selsabil Daboussi
Samia Essebaa
Chiraz Aichaouia
Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
F1000Research
Mepolizumab
Idiopathic chronic eosinophilic pneumonia
Corticosteroid
Treatment
eng
title Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
title_full Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
title_fullStr Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
title_full_unstemmed Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
title_short Case Report: Mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia [version 3; peer review: 2 approved]
title_sort case report mepolizumab in the treatment of idiopathic chronic eosinophilic pneumonia version 3 peer review 2 approved
topic Mepolizumab
Idiopathic chronic eosinophilic pneumonia
Corticosteroid
Treatment
eng
url https://f1000research.com/articles/12-337/v3
work_keys_str_mv AT moetemrizied casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved
AT samiramhamdi casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved
AT ghedirahela casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved
AT aidaayadi casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved
AT selsabildaboussi casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved
AT samiaessebaa casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved
AT chirazaichaouia casereportmepolizumabinthetreatmentofidiopathicchroniceosinophilicpneumoniaversion3peerreview2approved